BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Medical Diagnostic

Lumonus Partners With Smarter Radiation Oncology® to Expand AI-Driven, Standardised Cancer Care Worldwide

Lumonus, a healthcare technology company transforming cancer care with its AI-powered platform, announced a multi-year agreement with Smarter Radiation Onc...

September 30, 2025 | News

COREE Identifies First-Ever Microbiome Biomarkers for Diabetes and Obesity Patients

COREE announced on September 15 that it had, for the first time in the world, identified microbiome biomarkers specific to diabetes and obesity p...

September 29, 2025 | News

Leo Cancer Care and Sumitomo Heavy Industries Partner to Launch Upright Proton Therapy Solution

Leo Cancer Care, a leader in innovative cancer care solutions, and Sumitomo Heavy Industries, a global pioneer in medical technology, have announced a stra...

September 29, 2025 | News

Noul Secures FDA Registration for miLab™ CER Cervical Cancer Diagnostic, Paving Way for US Market Entry

Noul Co., Ltd. (CEO: David Lim), a medical AI company specializing in blood and cancer diagnostics, announced that FDA registration has been completed...

September 26, 2025 | News

Lunit and CellCarta Form Global Partnership to Advance AI-Powered Pathology in Clinical Trials

Lunit , a leading provider of AI for cancer diagnostics and biomarkers for oncology therapeutics, announced a strategic partnership with CellCarta, a globa...

September 25, 2025 | News

QIAGEN and APAGE Convene Asia-Pacific Experts to Set New Consensus on GI Infection Diagnostics

QIAGEN, in collaboration with APAGE, organized a regional meeting in Malaysia to share insights in GI diagnostics Over 10 leading key opinio...

September 24, 2025 | News

Lunit and Agilent Forge Collaboration to Develop AI-Powered Companion Diagnostics

Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabili...

September 23, 2025 | News

DEBRA Research and Nonsense Therapeutics Launch ReadOn Therapeutics to Advance Treatments for Epidermolysis Bullosa

DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug development for those affected by Epidermolysis bullosa (EB...

September 23, 2025 | News

China’s NMPA Approves Innovent’s Mazdutide, the World’s First Dual GCG/GLP-1 Receptor Agonist for Type 2 Diabetes

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatm...

September 22, 2025 | News

Ono Pharmaceutical Wins EU Approval for Vimseltinib as First TGCT Therapy

Vimseltinib is the first and only therapy with marketing authorization for the treatment of TGCT in the European Union Ono Pharmaceutical Co., a...

September 19, 2025 | News

Johnson & Johnson’s Amivantamab–Lazertinib Combo Extends Survival Beyond Four Years in Asia NSCLC Cohort

Median overall survival in Asia cohort is projected to exceed four years, demonstrating a durable benefit and surpassing osimertinib monotherapy by more th...

September 17, 2025 | News

Co-Diagnostics Signs Saudi MOU to Establish Joint Venture for PCR Manufacturing and Distribution in the Middle East

The Memorandum of Understanding includes the formation of a Joint Venture in the Kingdom of Saudi Arabia for manufacturing and distribution of th...

September 17, 2025 | News

Roche Expands AI-Enabled Accu-Chek SmartGuide CGM with mySugr App Integration Across Europe, Latin America and Asia-Pacific

The integration of Accu-Chek SmartGuide's AI-enabled predictive CGM with the popular mySugr app delivers a simple, intuitive solution...

September 17, 2025 | News

Japan Approves Novocure’s Optune Lua for Concurrent Use with PD-1/PD-L1 Inhibitors in Advanced NSCLC

Optune Lua is now approved for use concurrently with PD-1/PD-L1 inhibitors in adult patients with unresectable advanced/recurrent NSCLC who progressed on...

September 17, 2025 | News

Stay Connected